Amryt Pharma, Proactis Holdings and PCF Group
Episode 2193, Dec 09, 2020, 01:26 PM
Amryt Pharma discusses their $40m Private Placement with Leading Biotech Investors. Proactis Holdings signs its first bePayd contract. PCF Group preliminary results for the year.
On the Vox Markets Podcast Today: 9th December 2020
Joe Wiley, CEO of Amryt Pharma #AMYT discusses their $40m Private Placement with Leading Biotech Investors and how being listed on NASDAQ has increased interest in the company.
Tim Sykes, Chief Executive Officer at Proactis Holdings #PHD discusses the significance of signing its first contract for the provision of its accelerated payment service, bePayd.
(Interview starts at 11 minutes 9 seconds)
Scott Maybury, Chief Executive Officer of PCF Group #PCF talks about their preliminary results for the year and gives his outlook for a positive 2021.
(Interview starts at 16 minutes 13 seconds)
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast